Search

New Research Validates QMST in the Development of Epigenetic Medicines

Breakthrough results in quadruplex science! A research group at the University of Cambridge found quadruplex-stranded DNA in healthy human cells for the first time, as displayed in their publication in Nature. University of Cambridge researchers directly observed DNA quadruplex structures as controllers of gene expression in human cells. First author Marco Di Antonio states that “this forces us to rethink the biology of DNA.”


This finding confirms the revolutionary discoveries made by Reglagene’s CSO Laurence Hurley. Reglagene was founded on the thought of targeting quadruplex structures in cancer genes. By doing this, we can target specific genes and regulate their protein production. Today, Reglagene applies Quadruplex Master Switch Technology (QMST) to create and develop Epigenetic Medicines that save patient lives.

Read more: https://www.newscientist.com/article/2249390-quadruple-stranded-dna-seen-in-healthy-human-cells-for-the-first-time/#ixzz6SrxqJxrn


Recent Posts

See All

Reglagene highlighted in Arizona Daily Star

Reglagene highlighted in Arizona Daily Star feature on Tucson's Desert Angels. Reglagene is a portfolio company of the Desert Angels, and the initial funding was critical for our success. “If the Dese